Yuequan Wang
- Biomedical Engineering top 5%
- Molecular Biology
- Biomaterials top 5%
- Materials Chemistry
- Pulmonary and Respiratory Medicine
- Topics
- Nanoplatforms for cancer theranostics (29 papers)Nanoparticle-Based Drug Delivery (18 papers)Photodynamic Therapy Research Studies (10 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yuequan Wang
54 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Biomedical Engineering 571
- Molecular Biology 350
- Biomaterials 306
- Materials Chemistry 166
- Pulmonary and Respiratory Medicine 158
Countries citing papers authored by Yuequan Wang
This map shows the geographic impact of Yuequan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuequan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuequan Wang more than expected).
Fields of papers citing papers by Yuequan Wang
This network shows the impact of papers produced by Yuequan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuequan Wang. The network helps show where Yuequan Wang may publish in the future.
Co-authorship network of co-authors of Yuequan Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Yuequan Wang. A scholar is included among the top collaborators of Yuequan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuequan Wang. Yuequan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapybreakdown → | 23 |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 19 | |
| 8 | 4 | |
| 9 | 11 | |
| 10 | 14 | |
| 11 | 0 | |
| 12 | 5 | |
| 13 | 9 | |
| 14 | 90 | |
| 15 | 14 | |
| 16 | 42 | |
| 17 | 43 | |
| 18 | 62 | |
| 19 | 20 | |
| 20 | 11 |
About Yuequan Wang
Yuequan Wang is a scholar working on Biomaterials, Biomedical Engineering and Mechanics of Materials, having authored 60 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (29 papers), Nanoparticle-Based Drug Delivery (18 papers) and Photodynamic Therapy Research Studies (10 papers). The work is most often cited by research in Biomaterials (306 citations), Biomedical Engineering (571 citations) and Cancer Research (78 citations). Yuequan Wang has collaborated with scholars based in China, United States and France. Frequent co-authors include Cong Luo, Zhonggui He, Jin Sun, Shenwu Zhang, Xuanbo Zhang, Bingjun Sun, Shumeng Li, Mingbo Tong, Andy C.W. Chui and Zhiqiang Zhao. Their work appears in journals such as Nature Communications, ACS Nano and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.